Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Thrombosis Research|January 8, 2013
Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort studyElham Rahme, Guillaume Feugère, Caroline Sirois, et al.Journal of Thrombosis and Thrombolysis|June 27, 2016
A post hoc analysis of dalteparin versus oral anticoagulant (VKA) therapy for the prevention of recurrent venous thromboembolism (rVTE) in patients with cancer and renal impairmentSeth Woodruff, Guillaume Feugère, Paula Abreu, et al.Journal of Thrombosis and Thrombolysis|March 13, 2019
Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT StudySeth Woodruff, Agnes Y Y Lee, Marc Carrier, et al.Current Oncology (Toronto, Ont.)|April 26, 2024
Real-World Treatment Patterns and Clinical Outcomes among Patients Receiving CDK4/6 Inhibitors for Metastatic Breast Cancer in a Canadian Setting Using AI-Extracted DataRuth Moulson, Guillaume Feugère, Tracy S Moreira-Lucas, et al.Current Oncology (Toronto, Ont.)|February 26, 2026
Real-World Utilization of Palbociclib as First-Line Treatment for Canadian HR+/HER2- Women with Metastatic Breast Cancer: Results from PALCAN StudyDaniel Rayson, Jonathan Bertin, Maxim Lemelin, et al.Canadian Journal of Kidney Health and Disease|December 14, 2018
An Adjustable Dalteparin Sodium Dose Regimen for the Prevention of Clotting in the Extracorporeal Circuit in Hemodialysis: A Clinical Trial of Safety and Efficacy (the PARROT Study)Steven Soroka, Mohsen Agharazii, Sandra Donnelly, et al.Pageof 1